These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Investigation of malignant hyperthermia susceptibility in Denmark. Ording H Dan Med Bull; 1996 Apr; 43(2):111-25. PubMed ID: 8741205 [No Abstract] [Full Text] [Related]
17. Lymphocyte-based determination of susceptibility to malignant hyperthermia: a pilot study in swine. Bina S; Capacchione J; Muldoon S; Bayarsaikhan M; Bunger R Anesthesiology; 2010 Oct; 113(4):917-24. PubMed ID: 20823761 [TBL] [Abstract][Full Text] [Related]
18. "Noninvasive" testing for malignant hyperthermia susceptibility. Allen PD; López JR Anesthesiology; 2002 Nov; 97(5):1045-6. PubMed ID: 12411783 [No Abstract] [Full Text] [Related]
19. Diagnosis of susceptibility to malignant hyperthermia in man. Ording H Br J Anaesth; 1988 Feb; 60(3):287-302. PubMed ID: 3279989 [No Abstract] [Full Text] [Related]
20. Susceptibility to malignant hyperthermia detected non-invasively. Payen JF; Bourdon L; Mezin P; Jacquot C; le Bas JF; Stieglitz P; Benabid AL Lancet; 1991 Jun; 337(8756):1550-1. PubMed ID: 1675403 [No Abstract] [Full Text] [Related] [Next] [New Search]